ZNTL

Zentalis Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 6/10
  • Value↓ 4/10
Zentalis Pharmaceuticals sales and earnings growth
ZNTL Growth
Good
  • Revenue Y/Y↑ 100.00%
  • EPS Y/Y↑ 44.73%
  • FCF Y/Y↑ 17.62%
Zentalis Pharmaceuticals gross and profit margin trends
ZNTL Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -51.44%
Zentalis Pharmaceuticals net debt vs free cash flow
ZNTL Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Zentalis Pharmaceuticals stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks